Key Articles and Guidelines in the Management of Chronic Coronary Disease

Cardiovascular disease remains the leading cause of death; however, advances in the acute management of cardiovascular events have resulted in a greater number of patients who require chronic management to prevent future events. The care of these patients in the post-acute care phase was historically referred to as stable ischemic heart disease (SIHD) but is now collectively referred to as chronic coronary disease (CCD). In 2023, the chronic coronary disease guidelines were released and consolidated prior guidelines on secondary prevention and managing stable ischemic heart disease. The role of pharmacotherapy for CCD has expanded significantly in recent decades due to emerging evidence from clinical trials and the development of novel drug therapies. This manuscript summarizes key articles and guidelines that will serve as an important resource for clinicians responsible for caring for patients with chronic coronary disease.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy Practice
Published
2025-10-29
DOI
https://doi.org/10.1177/08971900251394069
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Key Articles and Guidelines in the Management of Chronic Coronary Disease

Michael S. Kelly, Dave L. Dixon, Mark Munger, Kelly C. Rogers et al.
Journal of Pharmacy Practice
Acute Myocardial Infarction Research
article

Key Articles and Guidelines in the Management of Chronic Coronary Disease

Michael S. Kelly, Dave L. Dixon, Mark Munger, Kelly C. Rogers, Tracy E. Macaulay, Nicholas B. Norgard, Toby C. Trujillo, Yun Lu, Tomasz Jurga, Dejan Landup
article en

Abstract

Cardiovascular disease remains the leading cause of death; however, advances in the acute management of cardiovascular events have resulted in a greater number of patients who require chronic management to prevent future events. The care of these patients in the post-acute care phase was historically referred to as stable ischemic heart disease (SIHD) but is now collectively referred to as chronic coronary disease (CCD). In 2023, the chronic coronary disease guidelines were released and consolidated prior guidelines on secondary prevention and managing stable ischemic heart disease. The role of pharmacotherapy for CCD has expanded significantly in recent decades due to emerging evidence from clinical trials and the development of novel drug therapies. This manuscript summarizes key articles and guidelines that will serve as an important resource for clinicians responsible for caring for patients with chronic coronary disease.

Journal of Pharmacy Practice
University of Minnesota (US), University of Kentucky (US), University of Tennessee Health Science Center (US), Virginia Commonwealth University (US), American Association of Colleges of Pharmacy (US), University of Utah (US), American Pharmacists Association (US), University of Minnesota System (US), Jefferson College of Health Sciences (US), Advocate Health Care (US), VA Ann Arbor Healthcare System (US), Hennepin Healthcare Research Institute (US), University of Montana (US), University of Tennessee at Knoxville (US), University of Missouri–Kansas City (US), Jefferson College (US)
Openalex Percentile: Top 53%
Acute Myocardial Infarction Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.